Intelligence / Healthtech / FDA 510(k) Clearances / Abbott Diabetes Care
Approvalsdevice cleared25 Aug 2026
Abbott Diabetes Care
25 Aug 2026: Device cleared · Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System. Recorded in the openFDA device 510(k) data.
- Decided
- 25 Aug 2026
- Device
- Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System
- Specialty
- Clinical Chemistry
- Country
- United States
- Location
- Alameda, CA
- Clearance type
- Direct
- 510(k) number
- DEN250049
- Submitted
- 2025-09-29
What this signal means
A clearance starts commercialisation: distribution, reimbursement, software and sales hires.
- 268 added in the 30 days to 9 Nov 2026.
- Cardiovascular leads with 122 clearances, then Radiology (107).
Reach them with AOS
Find the decision makers at Abbott Diabetes Care
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.
Across AOS Research
Other records for Abbott Diabetes Care in our registers.
More in Clinical Chemistry
FDA 510(k) Clearances
6 NovSiemens Healthcare Diagnostics, Inc.device cleared · Atellica IM Vitamin D Total II (VitDII)Approvals30 OctChangsha Sinocare, Inc.device cleared · Safe AQ Easy Blood Glucose Monitoring System; Safe AQ Care Blood Glucose Monitoring SystemApprovals28 OctCMT Health PTE., Ltd.device cleared · Profoject Safe Push Button Blood Collection SetsApprovals23 OctEPS Bio Technology Corp.device cleared · EASYMAX Voice Blood Glucose Monitoring SystemApprovals21 OctBeta Bionics, Inc.device cleared · Mint ACE PumpApprovals21 OctSol-Millennium Medical, Inc.device cleared · Sol-Guard Safety Pull Button Collection Set; Sol-Guard XtraThin Safety Pull-Button Blood Collection SetApprovals
Source: openFDA device 510(k) data, data to 9 Nov 2026. Devices FDA found substantially equivalent and cleared for the US market. Decision dates as published by FDA. AOS shows what the public record says; it does not verify or endorse the company.